Research Analysts Offer Predictions for CRNX FY2026 Earnings
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Crinetics Pharmaceuticals in a report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer expects that the company will earn ($4.87) per share for the year. The consensus estimate for Crinetics Pharmaceuticals’ current […]
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Crinetics Pharmaceuticals in a report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer expects that the company will earn ($4.87) per share for the year. The consensus estimate for Crinetics Pharmaceuticals’ current […]
